Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c516d1dc461b170764edf50df80538f |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-200833 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-173845 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-48 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D251-70 |
filingDate |
2003-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2005-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_345510d8c381b8f6dc1f8099d279459e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16f1554ac99d03e17f76727dd205c929 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24c602d8fbcbfb5b7623892af83bee07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb93018dd53a111a6a5c7f24890cf6d7 |
publicationDate |
2005-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-6906076-B2 |
titleOfInvention |
Compounds and methods of use to treat infectious diseases |
abstract |
The present invention concerns alkyl aryl carbonyl compounds that possess anti-infective activity. The compounds of the invention can be used to target specific nuclear localization signal, thereby blocking importation of specific proteins or molecular complex into the nucleus of a cell. The invention encompasses methods of use of such compounds for treatment or prevention of infectious diseases, such as parasitic and viral diseases, including, for example, malaria and acquired immunodeficiency syndrome. The use of the compounds to detect certain specific protein structures which are present in nuclear localization sequences is also taught. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006014760-A1 |
priorityDate |
1996-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |